System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Muriel Poublanc is an expert in Oncology at Oncopole Claudius Regaud (France). Muriel Poublanc has authored 18 publications, the most recent in 2023. SLR score: 35 (community average: 125). How the SLR is computed.

LeadR Profile

Muriel Poublanc Oncopole Claudius Regaud France
35 ScienceLeadR Reputation 35

Unlock

Register Login
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2023
Source: PubMed

Oncopole Claudius Regaud

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 18

Citations

Citations: 354 1st author: 0 Last author: 0 Unique author: 0

Main journals

BMC Cancer 3
Cancer Chemother Pharmacol 2
Ann Oncol 1
Blood 1
Cancer Res 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
PMID 37417948 — radiotherapy, brain neoplasms, drug therapy, glioblastoma, chemotherapy		Neuro Oncol202322
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae.
PMID 36471253 — head and neck neoplasms, analgesics, pain, capsaicin, neuralgia, lost to follow-up, cancer survivors		BMC Cancer20223
Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center.
PMID 33231298 — immunotherapy, neoplasms		Int J Cancer202013
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
PMID 32736540 — sarcoma, risk, drug therapy, neoplasm metastasis, disease-free survival, tissues, chemotherapy		BMC Cancer202011
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.
PMID 30791889 — glioblastoma, neoplasms, radiotherapy, intensity-modulated, chemoradiotherapy		BMC Cancer201948

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS